Fujian Wanchen Biotechnology Co. Ltd (300972) — Cash Flow Reinvestment Rate
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow Reinvestment Rate of 0.02x as of December 2025, reinvesting CN¥79.04 Million (capex CN¥77.44 Million plus investments CN¥1.60 Million) from operating cash flow of CN¥3.63 Billion. Explore Fujian Wanchen Biotechnology Co. Ltd (300972) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Fujian Wanchen Biotechnology Co. Ltd Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. Also explore Fujian Wanchen Biotechnology Co. Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year capital reinvestment analysis for Fujian Wanchen Biotechnology Co. Ltd. For live market cap and broader valuation context, see 300972 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | CN¥79.04 Million | CN¥3.63 Billion | CN¥77.44 Million | ▼ -84.2% |
| 2024 | 0.14x | CN¥116.65 Million | CN¥848.35 Million | CN¥116.65 Million | ▼ -66.9% |
| 2023 | 0.42x | CN¥425.60 Million | CN¥1.02 Billion | CN¥218.91 Million | ▼ -95.2% |
| 2022 | 8.67x | CN¥610.56 Million | CN¥70.38 Million | CN¥316.34 Million | ▲ +748.8% |
| 2021 | 1.02x | CN¥101.00 Million | CN¥98.82 Million | CN¥41.57 Million | ▲ +42.6% |
| 2020 | 0.72x | CN¥112.00 Million | CN¥156.24 Million | CN¥56.10 Million | ▲ +60.2% |
| 2019 | 0.45x | CN¥79.31 Million | CN¥177.28 Million | CN¥39.73 Million | — |